ISN 9.09% 6.0¢ isonea limited

isn rivals, page-20

  1. 8,443 Posts.
    lightbulb Created with Sketch. 175
    Great post chiasm, it's good to hear a doctors point of view who is the one that will influence their patients in what to buy and not to buy when it comes to asthma products.

    The thing that people don't understand is that ISN's product is not a nessesity as there are many other options as chiasm points out and as I pointed out last night in regards to competitors handheld devices.

    Even if there is an app, not every asthmatic has a smart phone and like I said the options are many when it comes to prevention and treatment.

    I highly doubt cash flow will be great from just this one product as i dont see it as being disruptive technology that everyone has to have but happy to be proven wrong.

    Just be carefull of all the hype.
 
watchlist Created with Sketch. Add ISN (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.